- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Apr 24, 2026 | 71.05M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 71.98M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 72.43M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 73.01M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2025 | 73.06M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $284.41M |
| Stock Repurchased | Q3 2026 · Mar 31, 2025 | $35.05M |
| Dividends Paid | Q3 2026 · Mar 31, 2026 | $127.46M |
| Dividends Paid | Q3 2026 · Mar 31, 2025 | $122.46M |
| Capex | Q3 2026 · Mar 31, 2026 | $46.62M |
| Capex | Q3 2026 · Mar 31, 2025 | $41.19M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $459.29M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | $314.39M |
| Long Term Debt | Q3 2026 · Mar 31, 2026 | $90M |
| Long Term Debt | Q3 2026 · Jun 30, 2025 | $0 |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $20.57M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $101.95M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $2.13B |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $2.13B |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $2.04B |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $341.13M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $535.78M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $915.75M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $913.14M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $594.84M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $681.46M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $3.05B |
| Total Assets | Q3 2026 · Jun 30, 2025 | $3.04B |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $1.71 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $5.41 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $1.52 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $4.49 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $1.71 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $5.42 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $1.53 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $4.50 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $72.17M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $211.97M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $66.35M |
| Sga Expense | Q3 2026 · Mar 31, 2025 | $209.84M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $45.11M |
| Rd Expense | Q3 2026 · Mar 31, 2026 | $126.62M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $39.41M |
| Rd Expense | Q3 2026 · Mar 31, 2025 | $120.19M |
| Net Income | Q3 2026 · Mar 31, 2026 | $122.89M |
| Net Income | Q3 2026 · Mar 31, 2026 | $391.55M |
| Net Income | Q3 2026 · Mar 31, 2025 | $111.11M |
| Net Income | Q3 2026 · Mar 31, 2025 | $328.14M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $155.05M |
| Operating Income | Q3 2026 · Mar 31, 2026 | $498.26M |
| Operating Income | Q3 2026 · Mar 31, 2025 | $138.74M |
| Operating Income | Q3 2026 · Mar 31, 2025 | $413.02M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $363.92M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $1.06B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $340.59M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2025 | $1.02B |
| Revenue | Q3 2026 · Mar 31, 2026 | $636.25M |
| Revenue | Q3 2026 · Mar 31, 2026 | $1.9B |
| Revenue | Q3 2026 · Mar 31, 2025 | $585.09M |
| Revenue | Q3 2026 · Mar 31, 2025 | $1.76B |